Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng, +202

The Lancet

Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma +6

MELD score to predict outcome in adult patients with non‐acetaminophen‐induced acute liver failure

Aezam Katoonizadeh, Jochen Decaestecker, Alexander Wilmer, +8

Liver International

The contribution of inflammatory astrocytes to BBB impairments in a brain-chip model of Parkinson’s disease

Aurélie de Rus Jacquet, Melanie Alpaugh, Hélèna L. Denis, +10

Nature Communications

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after <scp>HB</scp> eAg seroconversion is associated with high relapse rates and fatal outcomes

Stijn Van Hees, Stefan Bourgeois, Hans Van Vlierberghe, +18

Alimentary Pharmacology & Therapeutics

The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C‐infected patients treated with direct‐acting antivirals with and without pegylated interferon: A Belgian experience

Rob Bielen, Christophe Moreno, Hans Van Vlierberghe, +15

Journal of Viral Hepatitis

ImmunodeficienciesImmunologyPathologyRecurrence RatesAutoimmune Liver Disease +19

Belgian experience with direct acting antivirals in people who inject drugs

Rob Bielen, Christophe Moreno, Hans Van Vlierberghe, +15

Drug and Alcohol Dependence

VaccinationTreatment And PreventionMedicineAntiviral Drug DevelopmentAntiviral Therapy +6

A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pegfilgrastim in Patients Receiving First-Line FOLFOX/Bevacizumab or FOLFIRI/Bevacizumab for Locally Advanced or Metastatic Colorectal Cancer: Final Results of the Pegfilgrastim and Anti-VEGF Evaluation Study (PAVES)

Tamás Pintér, Zandra Klippel, Alvydas Česas, +14

Clinical Colorectal Cancer

Gastrointestinal OncologyMedicinePhase IiiFirst-line Folfox/bevacizumabClinical Trials +8

Viral clade is associated with severity of symptomatic genotype 3 hepatitis E virus infections in Belgium, 2010–2018

Michael Peeters, Julie Schenk, Thomas De Somer, +41

Journal of Hepatology

EpidemiologyViral HepatitisHepatitisVirologySymptomatic Genotype 3 +3

Endoscopic treatment of an iatrogenic perforation of the colon by using endoloop

Carla Celestino, Carlos Harz, Jochen Decaestecker, +1

Gastrointestinal Endoscopy

Iatrogenic PerforationEndoscopic TreatmentColorectal SurgeryGastroenterologyGi Technique +4

<i>NPY</i> Methylated ctDNA is a Promising Biomarker for Treatment Response Monitoring in Metastatic Colorectal Cancer

Katleen Janssens, Greetje Vanhoutte, Willem Lybaert, +11

Clinical Cancer Research